Involvement of cholecystokinin 2 receptor in food intake regulation: Hyperphagia and increased fat deposition in cholecystokinin 2 receptor-deficient mice

Endocrinology

Volumn 148, Issue 3, 2007, Pages 1039-1049

  Clerc, Pascal ^a   Constans, Maria Gràcia Coll ^a   Lulka, Hubert ^a,b   Broussaud, Stéphanie ^a   Guigné, Charlotte ^a   Leung Theung Long, Stéphane ^a   Perrin, Christophe ^c   Knauf, Claude ^c   Carpéné, Christian ^a   Pénicaud, Luc ^c   Seva, Catherine ^a   Burcelin, Rémy ^c   Valet, Philippe ^a   Fourmy, Daniel ^a   Dufresne, Marlène ^a  

^a INSERM   (France)

^b Plateau Technique de Lipidomique   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR; GASTRIN; GLUCOSE; INSULIN; PROOPIOMELANOCORTIN;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL METABOLISM; CONTROLLED STUDY; FEEDING BEHAVIOR; FOOD INTAKE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HYPERGLYCEMIA; HYPERPHAGIA; HYPOTHALAMUS; IMPAIRED GLUCOSE TOLERANCE; IN VITRO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULINEMIA; KNOCKOUT MOUSE; LIPID STORAGE; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADIPOSITY; ANIMALS; APPETITE REGULATION; BLOOD GLUCOSE; BODY WEIGHT; ENERGY METABOLISM; GLUCOSE TOLERANCE TEST; HYPERPHAGIA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, OBESE; MOTOR ACTIVITY; OBESITY; RECEPTOR, CHOLECYSTOKININ B;

EID: 33847045652     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-1064     Document Type: Article

References (56)

1. Dufresne M, Seva C, Fourmy D 2006 Cholecystokinin and gastrin receptors. Physiol Rev 86:805-847
2. Moran TH 2000 Cholecystokinin and satiety: current perspectives. Nutrition 16:858-865
3. Broberger C, Holmberg K, Shi TJ, Dockray G, Hokfelt T 2001 Expression and regulation of cholecystokinin and cholecystokinin receptors in rat nodose and dorsal root ganglia. Brain Res 903:128-140
4. Blevins JE, Hamel FG, Fairbairn E, Stanley BG, Reidelberger RD 2000 Effects of paraventricular nucleus injection of CCK-8 on plasma CCK-8 levels in rats. Brain Res 860:11-20
5. Blevins JE, Stanley BG, Reidelberger RD 2000 Brain regions where cholecystokinin suppresses feeding in rats. Brain Res 860:1-10
6. Baldwin BA, Parrott RF, Ebenezer IS 1998 Food for thought: a critique on the hypothesis that endogenous cholecystokinin acts as a physiological satiety factor. Prog Neurobiol 55:477-507
7. Kopin AS, Mathes WF, McBride EW, Nguyen M, Al-Haider W, Schmitz F, Bonner-Weir S, Kanarek R, Beinborn M 1999 The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J Clin Invest 103:383-391
8. Broberger C, Hokfelt T 2001 Hypothalamic and vagal neuropeptide circuitries regulating food intake. Physiol Behav 74:669-682
9. Moriarty P, Dimaline R, Thompson DG, Dockray GJ 1997 Characterization of cholecystokinin A and cholecystokinin B receptors expressed by vagal afferent neurons. Neuroscience 79:905-913
10. Burdakov D, Ashcroft FM 2002 Cholecystokinin tunes firing of an electrically distinct subset of arcuate nucleus neurons by activating A-type potassium channels. J Neurosci 22:6380-6387
11. Cano V, Caicoya E, Ruiz-Gayo M 2003 Effect of peripheral cholecystokinin receptor agonists on c-Fos expression in brain sites mediating food consumption in rats. Neurosci Lett 343:13-16
12. Noble F, Wank SA, Crawley JN, Bradwejn J, Seroogy KB, Hamon M, Roques BP 1999 International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol Rev 51:745-781
13. Noble F, Roques BP 2002 Phenotypes of mice with invalidation of cholecystokinin (CCK(1) or CCK(2)) receptors. Neuropeptides 36:157-170
14. Miyasaka K, Ohta M, Kanai S, Yoshida Y, Sato N, Nagata A, Matsui T, Noda T, Jimi A, Takiguchi S, Takata Y, Kawanami T, Funakoshi A 2004 Enhanced gastric emptying of a liquid gastric load in mice lacking cholecystokinin-B receptor: a study of CCK-A,B, and AB receptor gene knockout mice. J Gastroenterol 39:319-323
15. Kissileff HR, Carretta JC, Geliebter A, Pi-Sunyer FX 2003 Cholecystokinin and stomach distension combine to reduce food intake in humans. Am J Physiol Regul Integr Comp Physiol 285:R992-R998
16. Miyasaka K, Ichikawa M, Ohta M, Kanai S, Yoshida Y, Masuda M, Nagata A, Matsui T, Noda T, Takiguchi S, Takata Y, Kawanami T, Funakoshi A 2002 Energy metabolism and turnover are increased in mice lacking the cholecystokinin-B receptor. J Nutr 132:739-741
17. Weiland TJ, Voudouris NJ, Kent S 2004 The role of CCK2 receptors in energy homeostasis: insights from the CCK2 receptor-deficient mouse. Physiol Behav 82:471-476
18. Areda T, Raud S, Philips MA, Innos J, Matsui T, Koks S, Vasar E, Karis A, Asser T 2006 Cat odour exposure decreases exploratory activity and alters neuropeptide gene expression in CCK(2) receptor deficient mice, but not in their wild-type littermates. Behav Brain Res 169:212-219
19. Runkorg K, Veraksits A, Kurrikoff K, Luuk H, Raud S, Abramov U, Matsui T, Bourin M, Koks S, Vasar E 2003 Distinct changes in the behavioural effects of morphine and naloxone in CCK2 receptor-deficient mice. Behav Brain Res 144:125-135
20. Koks S, Abramov U, Veraksits A, Bourin M, Matsui T, Vasar E 2003 CCK2 receptor-deficient mice have increased sensitivity of dopamine D2 receptors. Neuropeptides 37:25-29
21. Singh P, Cobb S, Rengifo-Cam W, Deng X, Willis W, Li Q 2004 Locomotor activity and behavior of mutant mice deleted for gastrin gene expression. J Physiol Pharmacol 55:269-278
22. Cowey SL, Quast M, Belalcazar LM, Wei J, Deng X, Given R, Singh P 2005 Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression. Cancer 103:2643-2653
23. Nagata A, Ito M, Iwata N, Kuno J, Takano H, Minowa O, Chihara K, Matsui T, Noda T 1996 G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proc Natl Acad Sci USA 93:11825-11830
24. Saillan-Barreau C, Dufresne M, Clerc P, Sanchez D, Corominola H, Moriscot C, Guy-Crotte O, Escrieut C, Vaysse N, Gomis R, Tarasova N, Fourmy D 1999 Evidence for a functional role of the cholecystokinin-B/gastrin receptor in the human fetal and adult pancreas. Diabetes 48:2015-2021
25. Iglesias-Osma MC, Garcia-Barrado MJ, Visentin V, Pastor-Mansilla MF, Bour S, Prevot D, Valet P, Moratinos J, Carpene C 2004 Benzylamine exhibits insulin-like effects on glucose disposal, glucose transport, and fat cell lipolysis in rabbits and diabetic mice. J Pharmacol Exp Ther 309:1020-1028
26. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
27. Burcelin R, Crivelli V, Dacosta A, Roy-Tirelli A, Thorens B 2002 Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. Am J Physiol Endocrinol Metab 282:E834-E842
28. Fourmy D, Lopez P, Poirot S, Jimenez J, Dufresne M, Moroder L, Powers SP, Vaysse N 1989 A new probe for affinity labelling pancreatic cholecystokinin receptor with minor modification of its structure. Eur J Biochem 185:397-403
29. Escrieut C, Gigoux V, Archer E, Verrier S, Maigret B, Behrendt R, Moroder L, Bignon E, Silvente-Poirot S, Pradayrol L, Fourmy D 2002 The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor. Evidence for a crucial role of Met-121 in the activation process. J Biol Chem 277:7546-7555
30. Gully D, Frehel D, Marcy C, Spinazze A, Lespy L, Neliat G, Maffrand JP, Le Fur G 1993 Peripheral biological activity of SR 27,897: a new potent non-peptide antagonist of CCKA receptors. Eur J Pharmacol 232:13-19
31. Perrin C, Knauf C, Burcelin R 2004 Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside, controls muscle glycogen synthesis. Endocrinology 145:4025-4033
32. Bertrand P, Bohme GA, Durieux C, Guyon C, Capet M, Jeantaud B, Boudeau P, Ducos B, Pendley CE, Martin GE, Floch A, Doble A 1994 Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKB/gastrin receptor antagonists. Eur J Pharmacol 262:233-245
33. Attoub S, Levasseur S, Buyse M, Goiot H, Laigneau JP, Moizo L, Hervatin F, Le Marchand-Brustel Y, Lewin JM, Bado A 1999 Physiological role of cholecystokinin B/gastrin receptor in leptin secretion. Endocrinology 140:4406-4410
34. Ohki-Hamazaki H, Watase K, Yamamoto K, Ogura H, Yamano M, Yamada K, Maeno H, Imaki J, Kikuyama S, Wada E, Wada K 1997 Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature 390:165-169
35. Yaswen L, Diehl N, Brennan MB, Hochgeschwender U 1999 Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 5:1066-1070
36. Takahashi K, Suwa H, Ishikawa T, Kotani H 2002 Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype. J Clin Invest 110:1791-1799
37. Nonogaki K, Strack AM, Dallman MF, Tecott LH 1998 Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat Med 4:1152-1156
38. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K, Matsukura S 2002 Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87:240-244
39. Rajala MW, Qi Y, Patel HR, Takahashi N, Banerjee R, Pajvani UB, Sinha MK, Gingerich RL, Scherer PE, Ahima RS 2004 Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes 53:1671-1679
40. Way JM, Gorgun CZ, Tong Q, Uysal KT, Brown KK, Harrington WW, Oliver Jr WR, Willson TM, Kliewer SA, Hotamisligil GS 2001 Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor γ agonists. J Biol Chem 276:25651-25653
41. Tartare-Deckert S, Chavey C, Monthouel MN, Gautier N, Van Obberghen E 2001 The matricellular protein SPARC/osteonectin as a newly identified factor up-regulated in obesity. J Biol Chem 276:22231-22237
42. Boucher J, Masri B, Daviaud D, Gesta S, Guigne C, Mazzucotelli A, Castan-Laurell I, Tack I, Knibiehler B, Carpene C, Audigier Y, Saulnier-Blache JS, Valet P 2005 Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146:1764-1771
43. Saltiel AR 2001 You are what you secrete. Nat Med 7:887-888
44. Wang J, Obici S, Morgan K, Barzilai N, Feng Z, Rossetti L 2001 Overfeeding rapidly induces leptin and insulin resistance. Diabetes 50:2786-2791
45. Elmquist JK 2001 Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin. Physiol Behav 74:703-708
46. Bi S, Scott KA, Kopin AS, Moran TH 2004 Differential roles for cholecystokinin a receptors in energy balance in rats and mice. Endocrinology 145:3873-3880
47. Mercer LD, Le VQ, Nunan J, Jones NM, Beart PM 2000 Direct visualization of cholecystokinin subtype2 receptors in rat central nervous system using anti-peptide antibodies. Neurosci Lett 293:167-170
48. Malick A, Jakubowski M, Elmquist JK, Saper CB, Burstein R 2001 A neurohistochemical blueprint for pain-induced loss of appetite. Proc Natl Acad Sci USA 98:9930-9935
49. Furuse M, Ao R, Bungo T, Ando R, Shimojo M, Masuda Y, Saito N 1999 Central gastrin inhibits feeding behavior and food passage in neonatal chicks. Life Sci 65:305-311
50. Chen Q, Nakajima A, Meacham C, Tang YP 2006 Elevated cholecystokinin-ergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse. Proc Natl Acad Sci USA 103:3881-3886
51. Raud S, Runkorg K, Veraksits A, Reimets A, Nelovkov A, Abramov U, Matsui T, Bourin M, Volke V, Koks S, Vasar E 2003 Targeted mutation of CCK2 receptor gene modifies the behavioural effects of diazepam in female mice. Psychopharmacology (Berl) 168:417-425
52. Danzer M, Jocic M, Samberger C, Painsipp E, Bock E, Pabst MA, Crailsheim K, Schicho R, Lippe IT, Holzer P 2004 Stomach-brain communication by vagal afferents in response to luminal acid backdiffusion, gastrin, and gastric acid secretion. Am J Physiol Gastrointest Liver Physiol 286:G403-G411
53. Yakabi K, Iwabuchi H, Nakamura T, Endo K, Fukunaga Y, Kumaki I, Takayama K 2002 Neuronal expression of Fos protein in the brain after intravenous injection of gastrin in rats. Neurosci Lett 317:57-60
54. Fan W, Ellacott KL, Halatchev IG, Takahashi K, Yu P, Cone RD 2004 Cholecystokinin-mediated suppression of feeding involves the brainstem melanocortin system. Nat Neurosci 7:335-336
55. El-Salhy M 1998 Neuroendocrine peptides of the gastrointestinal tract of an animal model of human type 2 diabetes mellitus. Acta Diabetol 35:194-198
56. Baranowska B, Radzikowska M, Wasilewska-Dziubinska E, Roguski K, Borowiec M 2000 Disturbed release of gastrointestinal peptides in anorexia nervosa and in obesity. Diabetes Obes Metab 2:99-103